113 related articles for article (PubMed ID: 17982643)
1. Saliva as a biomarker for head and neck squamous cell carcinoma: in vitro detection of cytotoxic effects by using the plating efficiency index.
Bloching MB; Barnes J; Aust W; Knipping S; Neumann K; Grummt T; Naim R
Oncol Rep; 2007 Dec; 18(6):1551-6. PubMed ID: 17982643
[TBL] [Abstract][Full Text] [Related]
2. Smoking and drinking can induce p15 methylation in the upper aerodigestive tract of healthy individuals and patients with head and neck squamous cell carcinoma.
Chang HW; Ling GS; Wei WI; Yuen AP
Cancer; 2004 Jul; 101(1):125-32. PubMed ID: 15221997
[TBL] [Abstract][Full Text] [Related]
3. Salivary soluble CD44: a potential molecular marker for head and neck cancer.
Franzmann EJ; Reategui EP; Carraway KL; Hamilton KL; Weed DT; Goodwin WJ
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):735-9. PubMed ID: 15767360
[TBL] [Abstract][Full Text] [Related]
4. Single-nucleotide polymorphisms in DNA double-strand break repair genes: association with head and neck cancer and interaction with tobacco use and alcohol consumption.
Werbrouck J; De Ruyck K; Duprez F; Van Eijkeren M; Rietzschel E; Bekaert S; Vral A; De Neve W; Thierens H
Mutat Res; 2008 Oct; 656(1-2):74-81. PubMed ID: 18768166
[TBL] [Abstract][Full Text] [Related]
5. Increased sensitivity to bleomycin in upper aerodigestive tract mucosa of head and neck squamous cell carcinoma patients.
Jin C; Jin Y; Wennerberg J; Rosenquist B; Mertens F
Mutat Res; 2008 Mar; 652(1):30-7. PubMed ID: 18243046
[TBL] [Abstract][Full Text] [Related]
6. Tumor-specific methylation in saliva: a promising biomarker for early detection of head and neck cancer recurrence.
Righini CA; de Fraipont F; Timsit JF; Faure C; Brambilla E; Reyt E; Favrot MC
Clin Cancer Res; 2007 Feb; 13(4):1179-85. PubMed ID: 17317827
[TBL] [Abstract][Full Text] [Related]
7. Association of genetic polymorphisms in glutathione S-transferases and susceptibility to head and neck cancer.
Singh M; Shah PP; Singh AP; Ruwali M; Mathur N; Pant MC; Parmar D
Mutat Res; 2008 Feb; 638(1-2):184-94. PubMed ID: 18035380
[TBL] [Abstract][Full Text] [Related]
8. Salivary glutathione and uric acid levels in patients with head and neck squamous cell carcinoma.
Almadori G; Bussu F; Galli J; Limongelli A; Persichilli S; Zappacosta B; Minucci A; Paludetti G; Giardina B
Head Neck; 2007 Jul; 29(7):648-54. PubMed ID: 17274058
[TBL] [Abstract][Full Text] [Related]
9. Increased mitochondrial DNA content in saliva associated with head and neck cancer.
Jiang WW; Masayesva B; Zahurak M; Carvalho AL; Rosenbaum E; Mambo E; Zhou S; Minhas K; Benoit N; Westra WH; Alberg A; Sidransky D; Koch W; Califano J
Clin Cancer Res; 2005 Apr; 11(7):2486-91. PubMed ID: 15814624
[TBL] [Abstract][Full Text] [Related]
10. [Cytogenetic and hormonal changes in head and neck squamous cell cancer patients: potential biomarkers for functional approaches in surgical oncology].
Remenár E
Magy Onkol; 2009 Jun; 53(2):157-64. PubMed ID: 19581182
[TBL] [Abstract][Full Text] [Related]
11. Detection of head and neck squamous cell carcinoma among exfoliated oral mucosal cells by microsatellite analysis.
Spafford MF; Koch WM; Reed AL; Califano JA; Xu LH; Eisenberger CF; Yip L; Leong PL; Wu L; Liu SX; Jerónimo C; Westra WH; Sidransky D
Clin Cancer Res; 2001 Mar; 7(3):607-12. PubMed ID: 11297256
[TBL] [Abstract][Full Text] [Related]
12. Pre-analytic saliva processing affect proteomic results and biomarker screening of head and neck squamous carcinoma.
Ohshiro K; Rosenthal DI; Koomen JM; Streckfus CF; Chambers M; Kobayashi R; El-Naggar AK
Int J Oncol; 2007 Mar; 30(3):743-9. PubMed ID: 17273777
[TBL] [Abstract][Full Text] [Related]
13. Head and neck squamous cell carcinoma in non-smoking and non-drinking patients with multiple tumors: etiologic significance of p53 and Ki-67 in non-tumorous epithelium.
Farshadpour F; Hordijk GJ; Koole R; Slootweg PJ
J Oral Pathol Med; 2008 Oct; 37(9):549-54. PubMed ID: 18331287
[TBL] [Abstract][Full Text] [Related]
14. Influence of the persistence of tobacco and alcohol use in the appearance of second neoplasm in patients with a head and neck cancer. A case-control study.
León X; del Prado Venegas M; Orús C; López M; García J; Quer M
Cancer Causes Control; 2009 Jul; 20(5):645-52. PubMed ID: 19067191
[TBL] [Abstract][Full Text] [Related]
15. Global DNA methylation level in whole blood as a biomarker in head and neck squamous cell carcinoma.
Hsiung DT; Marsit CJ; Houseman EA; Eddy K; Furniss CS; McClean MD; Kelsey KT
Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):108-14. PubMed ID: 17220338
[TBL] [Abstract][Full Text] [Related]
16. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers.
Gillison ML; D'Souza G; Westra W; Sugar E; Xiao W; Begum S; Viscidi R
J Natl Cancer Inst; 2008 Mar; 100(6):407-20. PubMed ID: 18334711
[TBL] [Abstract][Full Text] [Related]
17. [Validity of chromosome analysis and bleomycin sensitivity assay in the prevention of head and neck cancer in Hungary].
Székely G; Remenár E; Kásler M; Bodrog A; Gundy S
Orv Hetil; 2001 Mar; 142(12):611-6. PubMed ID: 11324219
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of human papillomavirus and other risk factors in Lithuanian patients with head and neck cancer.
Gudleviciene Z; Smailyte G; Mickonas A; Pikelis A
Oncology; 2009; 76(3):205-8. PubMed ID: 19209011
[TBL] [Abstract][Full Text] [Related]
19. Soluble CD44 is a potential marker for the early detection of head and neck cancer.
Franzmann EJ; Reategui EP; Pedroso F; Pernas FG; Karakullukcu BM; Carraway KL; Hamilton K; Singal R; Goodwin WJ
Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1348-55. PubMed ID: 17627000
[TBL] [Abstract][Full Text] [Related]
20. [In vitro determination of the cytotoxic activity of saliva samples of smokers].
Bloching M; Stephan D; Berghaus A; Lautenschläger C; Grummt T
HNO; 2001 Aug; 49(8):630-5. PubMed ID: 11544884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
